arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Genmab A/S

GMAB Health Care Biotechnology: Pharmaceutical Preparations
$33.60
Today
as of Sep 4, 16:49 ET
Last 30 days +15.86% Jul 28 → Sep 04
$28.05 $29.76 $31.47 $33.17 $34.88 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$33.96
High
$34.19
Low
$33.55
Volume
$1M
Avg Vol
$2M
Mkt Cap
$4.0B
P/E (TTM)
—
Beta
—
52w High
$35.43
52w Low
$23.62
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 17 items

Aug 26 · 23:57 Insider Monkey
Could Genmab (GMAB) Stock Win as Royalty Growth Fuels a New Earnings Cycle?
Aug 25 · 13:00 PR GlobeNewswire
Genmab to Participate in Upcoming Investor Conferences
Aug 13 · 23:38 Insider Monkey
Could AbbVie Inc. (ABBV) Win as Genmab A/S (GMAB) Faces a New Regulatory Test for Epcoritamab?
▸ Show all 17 press releases & news Free account →

Overview

52-week range
$24
$35
85% of range
Avg surprise (last 3)
+24.4%
Avg reaction (last 2)
-4.4%
0% positive
Latest IV / EM
64%
EM ±10.0% · $35 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.15$0.25$0.34$0.44$0.54 Actual $0.31Est $0.23Actual $0.54Est $0.39Actual $0.15Est $0.15 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $0.15 $0.15 0.0% -51.6% -3.0% earnings
Thu Aug 7, 2025Jun/2025 $0.54 $0.39 +38.5% — — earnings
Thu May 8, 2025Mar/2025 $0.31 $0.23 +34.8% — -5.7% earnings

Implied volatility — last 90 days

17%84%152%219%286% Jun 07 — IV 53% · EM ±7.4%Jun 11 — IV 50% · EM ±5.5%Jun 12 — IV 57% · EM ±5.8%Jun 16 — IV 253% · EM ±15.0%Jun 19 — IV 91% · EM ±20.2%Jun 22 — IV 58% · EM ±12.1%Jun 23 — IV 94% · EM ±19.3%Jun 24 — IV 67% · EM ±13.4%Jun 25 — IV 73% · EM ±14.3%Jun 26 — IV 100% · EM ±19.1%Jun 29 — IV 101% · EM ±17.9%Jun 30 — IV 119% · EM ±20.6%Jul 01 — IV 121% · EM ±20.3%Jul 02 — IV 96% · EM ±15.6%Jul 03 — IV 100% · EM ±15.6%Jul 06 — IV 115% · EM ±15.9%Jul 07 — IV 72% · EM ±9.5%Jul 08 — IV 46% · EM ±5.8%Jul 14 — IV 65% · EM ±4.7%Jul 20 — IV 72% · EM ±17.1%Jul 21 — IV 89% · EM ±20.6%Jul 22 — IV 65% · EM ±14.8%Jul 23 — IV 41% · EM ±9.3%Jul 24 — IV 53% · EM ±11.7%Jul 27 — IV 64% · EM ±13.3%Jul 28 — IV 51% · EM ±10.5%Jul 29 — IV 60% · EM ±11.9%Jul 30 — IV 70% · EM ±13.8%Jul 31 — IV 59% · EM ±11.3%Aug 03 — IV 72% · EM ±12.8%Aug 04 — IV 85% · EM ±14.6%Aug 05 — IV 73% · EM ±12.1%Aug 06 — IV 65% · EM ±10.5%Aug 07 — IV 66% · EM ±10.2%Aug 10 — IV 51% · EM ±7.1%Aug 11 — IV 40% · EM ±5.3%Aug 12 — IV 55% · EM ±6.9%Aug 13 — IV 51% · EM ±6.1%Aug 14 — IV 130% · EM ±14.4%Aug 17 — IV 65% · EM ±5.4%Aug 18 — IV 210% · EM ±15.2%Aug 20 — IV 287% · EM ±12.0%Aug 24 — IV 46% · EM ±9.5%Aug 25 — IV 49% · EM ±10.1%Aug 26 — IV 54% · EM ±10.7%Aug 27 — IV 46% · EM ±9.0%Aug 28 — IV 44% · EM ±8.4%Aug 31 — IV 37% · EM ±6.5%Sep 01 — IV 17% · EM ±3.0%Sep 02 — IV 27% · EM ±4.5%Sep 03 — IV 47% · EM ±7.6%Sep 04 — IV 64% · EM ±10.0%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in